Inclusion Criteria:

•Outpatient, male or female of any race, and at least 12 years of age. Female subjects of childbearing potential must have a negative urine pregnancy test result at baseline and practice a reliable method of contraception throughout the study.
•Mild to moderate, plaque-type psoriasis
•Target lesion on the trunk or extremities (excluding palms/soles, elbows, or knees) with a score of 2 or 3 for each of erythema, scaling and plaque thickness
•Able to understand the requirements of the study and sign Informed Consent/HIPAA Authorization Forms. Subjects under the legal age of consent in the state where the study is conducted must also have the written, informed consent of a parent or legal guardian.


Exclusion Criteria:

•Female subjects who are pregnant (positive urine pregnancy test) breast feeding or who are of childbearing potential and not practicing a reliable method of birth control
•Known allergy to clobetasol propionate or other topical corticosteroids; or to any component of the investigational formulations
•Subjects who have not complied with the proper wash-out periods for prohibited medications
•Medical condition that in the opinion of the investigator, contraindicates the subject's participation in the clinical study
•Skin disease/disorder that might interfere with the study related diagnosis or evaluations
•Evidence of recent alcohol or drug abuse
•History of poor cooperation, non-compliance with medical treatment or unreliability

• USA (click to view all sites in USA)
• Center for Dermatology, Cosmetic and Laser
  Fremont, CA, 94538; Completed;
  
• Dermatology Specialists
  Louisville, KY, 40202; Completed;